Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Sex — a potential factor affec...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Sex — a potential factor affecting immune checkpoint inhibitor therapy for cancers

Sex — a potential factor affecting immune checkpoint inhibitor therapy for cancers

Bibliographic Details
Main Authors: Wang Hu, Xinye Qian, Shuang Wang, Lu Gao, Jingyi Xu, Jun Yan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
sex
immune checkpoint inhibitor
efficiency
cancer
adverse event
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1024112/full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1024112/full

Similar Items

  • Nano-Chemotherapy synergize with immune checkpoint inhibitor- A better option?
    by: Xinye Qian, et al.
    Published: (2022-08-01)
  • Treatment-related adverse events of immune checkpoint inhibitors in clinical trials: a systematic review and meta-analysis
    by: Xin Shen, et al.
    Published: (2024-05-01)
  • Management of immune checkpoint inhibitor‐related adverse events: A review of case reports
    by: Xiaoyan Si, et al.
    Published: (2020-03-01)
  • Immune checkpoint inhibitor-associated ophthalmic adverse events: current understanding of its mechanisms, diagnosis, and management
    by: Yu-Wen Zhou, et al.
    Published: (2022-04-01)
  • Renal adverse effects following the use of different immune checkpoint inhibitor regimens: A real‐world pharmacoepidemiology study of post‐marketing surveillance data
    by: Gang Chen, et al.
    Published: (2020-09-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs